Status: Recruiting
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
A single arm phase II study of pembrolizumab, carboplatin, paclitaxel, and radiation for the treatment of early-stage anal cancer. There are 2 treatments phases and then surveillance. The first treatment phase is the chemoradiation phase (Cycle 1-6, weekly cycles) which is followed by the maintenance phase (Cycle 7-14, 6 week cycles).
Participants needed: 23
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Dustin DemingUpdated: Mar 23, 2026Locations: 4
Eligibility criteria
Written informed consent and HIPAA authorization for release of personal health... [+24]
Uncontrolled intercurrent illness including, but not limited to, ongoing or acti... [+14]